Remdesivir improved symptoms when administered to moderately ill COVID-19 patients: Gilead

… the company says its experimental medicinal remdesivir has improved symptoms if given for five days to moderately ill, hospitalized patients with COVID19. .



Source link

Be the first to comment on "Remdesivir improved symptoms when administered to moderately ill COVID-19 patients: Gilead"

Leave a comment

Your email address will not be published.


*